Our current research focuses solely on the neuroprotective potential of GST by altering the JAK-STAT/PPAR gamma signalling pathway and thereby alleviating behavioural, neurochemical, morphological, gross pathological, and histological changes in the PPA-induced experimental model of autism in adult rats. This evidence concerns the gene SOAT1 and autism.